Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Targeted Marrow Radiation (TMI) Improves Therapeutic Efficacy of STAT3 Decoy Molecules By Augmenting Its Delivery and Immune Modulation in an AML Mouse Model

Srideshikan Sargur Madabushi, PhD, Darren Zuro, Yu-Lin SU, PhD, Paresh Vishwasrao, MSc, Jamison Brooks, B.S, Liliana E Parra, James F Sanchez, PhD, Jeffrey Wong, MD, Marcin Kortylewski, PhD, Susanta Hui, PhD, DABR.

Blood (2019) 134 (Supplement_1): 3929.

https://doi.org/10.1182/blood-2019-127470

Published: 2019

Journal Articles

64 cu-DOTA-Anti-CD33 PET-CT Imaging for Acute Myeloid Leukemia and Image-Guided Treatment

Srideshikan Sargur Madabushi, PhD, Darren Zuro, Jamison Brooks, B.S, Bijender Kumar, PhD, Liliana E Parra, Marvin Orellana, B.S, Indu Nair, PhD, Junie Chea, Kofi Poku, PharmD, Ching-Cheng Chen, PhD, James Sanchez, PhD, John E. Shively, Daniel A. Vallera, PhD, Jeffrey Wong, MD, Anthony S. Stein, MD, David Colcher, PhD, Paul Yazaki, PhD, Susanta Hui, PhD, DABR.

Blood (2018) 132 (Supplement 1): 2747.

https://doi.org/10.1182/blood-2018-99-117878

Published: 2018

Journal Articles

Low-Toxicity/High-Efficacy HLA Haploidentical Transplantation for Elderly/Unfit Patients with Acute Leukemia

Andrea Velardi, MD, Alessandra Carotti, MD, Franca Falzetti, MD, Adelmo Terenzi, MD, Loredana Ruggeri, MD PhD, Antonio Pierini, MD PhD, Sara Piccinelli, MD, Sara Tricarico, MD, Amico Lucia, MD, Genni Casarola, MD, Valentina Lancillotta, MD, Simonetta Saldi, MD, Mauro Di Ianni, MD PhD, Cynthia Aristei, MD PhD, Massimo Fabrizio Martelli, MD PhD

Blood (2017) 130 (Supplement 1): 4601.

https://doi.org/10.1182/blood.V130.Suppl_1.4601.4601

Published: 2017

Journal Articles

Escalated Dose-Rates of Total Marrow Irradiation (TMI) Combined with Treosulfan and Fludarabine-Based Conditioning Chemotherapy Regimen for Chemosensitive Advanced Multiple Myeloma (MM) Patients Undergoing a Matched Allogeneic Stem-Cell Transplantation: First Results of a Phase I/II Prospective Monocentric Study (TrRaMM TMI)

Andrea Angelo Assanelli, MD, Francesca Lorentino, MD, Magda Marcatti, MD, Anna Chiara, MD, Tommaso Perini, MD, Maria Teresa Lupo Stanghellini, MD, Fabio Giglio, MD, Mara Morelli, MD, Raffaella Greco, MD, Sara Broggi, Physicist, Mauro Cattaneo, Physicist, Jacopo Peccatori, MD, Chiara Bonini, MD, Nadia Di Muzio, MD, Fabio Ciceri, MD

Blood (2016) 128 (22): 2221.

https://doi.org/10.1182/blood.V128.22.2221.2221

Published: 2016

Journal Articles

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Karen Sweiss, PharmD, John G. Quigley, MD, Santosh L. Saraf, MD, Irum Khan, MD, Eileen D. Hacker, PhD APN, AOCN, Nadim Mahmud, MD PhD, David J. Peace, MD, Howard Ozer, MD PhD, Jennifer Windhorst, APN, Ralph R Weichselbaum, MD, Damiano Rondelli, MD

Blood (2016) 128 (22): 4646.

https://doi.org/10.1182/blood.V128.22.4646.4646

Published: 2016

Journal Articles

Comparison of Oxidant Stress and Damage-Related Responses after Total Body Irradiation Versus Total Marrow Irradiation in Rodents

Susanta Hui, Yutaka Takahashi, Shernan G. Holtan, MD, Rezvan Azimi, Masashi Yagi, Jessie Ingvalson, Davis Seelig, Parham Alaei, Luke Arentsen, Lindsey Godin, Alex Domek, Michael Ehrhardt, Angela Panoskaltsis-Mortari, PhD

Blood (2014) 124 (21): 3804.

https://doi.org/10.1182/blood.V124.21.3804.3804

Published: 2014

Journal Articles

Myeloablative Fludarabine/ IV Busulfan Combined With Linac Based Intentsity Modulated Total Marrow Irradiation (IM-TMI) In Allogeneic Stem Cell Transplant For High Risk Hematologic Malignancies: A Phase I Study

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Nadim Mahmud, MD, PhD, David Peace, MD, John G. Quigley, MD, Santosh L. Saraf, MD, Enzo DeMasi, MD, Ralph R Weichselbaum, MD, Damiano Rondelli, MD

Blood (2013) 122 (21): 3285.

https://doi.org/10.1182/blood.V122.21.3285.3285

Published: 2013

Journal Articles

Phase I-II Trial of Tandem Autologous Transplantation with Melphalan Followed by Total Marrow Irradiation Ablative Therapy in Patients with Responding or Stable Mutiple Myeloma.

George Somlo, MD, Paul Frankel, PhD, Ricardo Spielberger, MD, Chatchada Karanes, MD, Amrita Krishnan, MD, Pablo Parker, MD, Leslie Popplewell, MD, Firoozeh Sahebi, MD, Timothy Schultheiss, PhD, Neil Martin Kogut, MD, David S. Snyder, MD, Anthony Selwyn Stein, M.D., Stephen J. Forman, MD, Jeffrey Wong, MD

Blood (2012) 120 (21): 3151.

https://doi.org/10.1182/blood.V120.21.3151.3151

Published: 2012

Journal Articles

Matched Cohort Analysis of Allogeneic Hematopoietic Cell Transplantation (HCT) with Total Marrow Irradiation/Fludarabine/Melphalan (TFM) Versus Fludarabine/Melphalan (FM) Conditioning for Acute Leukemia

Joseph Rosenthal, MD, Jefrrey Wong, MD, Anthony Selwyn Stein, MD, Tracy Stiller, Joycelynne Palmer, PHD, Stephen J. Forman, MD

Blood (2012) 120 (21): 222.

https://doi.org/10.1182/blood.V120.21.222.222

Published: 2012

Journal Articles

Linac Based Total Marrow Irradiation and Myeloablative Chemotherapy In Allogeneic Stem Cell Transplantation for High Risk Patients.

Pritesh R. Patel, MB, ChB, Bulent Aydogan, PhD, Damiano Rondelli, MD

Blood (2010) 116 (21): 4526.

https://doi.org/10.1182/blood.V116.21.4526.4526

Published: 2010

Journal Articles

Total Marrow Irradiation (TMI): A New Ablative Regimen as Part of Tandem (T) Autologous Peripheral Blood Progenitor Cell Transplant (AT) for Patients (pts) with Multiple Myeloma (MM).

George Somlo, M.D., F.A.C.P., Ricardo Spielberger, MD, Paul Frankel, Chatchada Karanes, MD, Amrita Krishnan, MD, FACP, Pablo Miguel Parker, MD, Leslie Popplewell, Firoozeh Sahebi, Tim Schultheiss, Neil Martin Kogut, MD, An Liu, David S. Snyder, MD, Stephen J. Forman, Jeffrey Y. Wong

Blood (2008) 112 (11): 3326.

https://doi.org/10.1182/blood.V112.11.3326.3326

Published: 2008

Journal Articles

A Randomized Comparison of Total-Marrow Irradiation, Busulfan and Cyclophosphamide with Tandem High-Dose Melphalan in Patients with Multiple Myeloma.

Stefan Knop, MD, Katja Bauer, Holger Hebart, MD, Hannes Wandt, MD, Lorenz Trumper, MD, Peter Liebisch, MD, Georg Maschmeyer, MD, Dietrich Peest, MD, Hans H. Wolf, MD, Nikolaus Kroger, MD, Christian Straka, MD, Michael Pfreundschuh, MD, Paolo Coser, MD, Christoph Meisner, PhD, Lothar Kanz, MD, Hermann Einsele, MD

Blood (2007) 110 (11): 728.

https://doi.org/10.1182/blood.V110.11.728.728

Published: 2007

Journal Articles

Total Marrow Irradiation (TMI) with Helical Tomotherapy and PBPC Following High-Dose Melphalan and PBPC as Part of Tandem Therapy for Patients with Multiple Myeloma.

George Somlo, MD, Stephen Forman, MD, Leslie Poppelwell, MD, Tim Schultheiss, PhD, Paul Frankel, Ph.D, Amrita Krishnan, MD, An Liu, PhD, Firoozeh Sahebi, MD, Parker Pablo, MD, Jeffrey Wong, MD

Blood (2005) 106 (11): 1176.

https://doi.org/10.1182/blood.V106.11.1176.1176

Published: 2005

Journal Articles

Single High-Dose Chemoradiotherapy Versus Tandem High Dose Melphalan Followed by Auto-SCT for Advanced Multiple Myeloma. Preliminary Analysissis.

Blood (2004) 104 (11): 537.

https://doi.org/10.1182/blood.V104.11.537.537

Published: 2004

Journal Articles

Tumor Necrosis Factor-α-Converting Enzyme (ADAM17) Mediates GPIbα Shedding from Platelets In Vitro and In Vivo .

Wolfgang Bergmeier, Ph.D., Crystal L. Piffath, Guiying Cheng, Vandana S. Dole, Ph.D., Yuhua Zhang, Ph.D., Ulrich H. von Andrian, Ph.D., Denisa D. Wagner, Ph.D.

Blood (2004) 104 (11): 841.

https://doi.org/10.1182/blood.V104.11.841.841

Published: 2004

NARROW

Targeted Marrow Radiation (TMI) Improves Therapeutic Efficacy of STAT3 Decoy Molecules By Augmenting Its Delivery and Immune Modulation in an AML Mouse Model

64 cu-DOTA-Anti-CD33 PET-CT Imaging for Acute Myeloid Leukemia and Image-Guided Treatment

Low-Toxicity/High-Efficacy HLA Haploidentical Transplantation for Elderly/Unfit Patients with Acute Leukemia

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Comparison of Oxidant Stress and Damage-Related Responses after Total Body Irradiation Versus Total Marrow Irradiation in Rodents

Myeloablative Fludarabine/ IV Busulfan Combined With Linac Based Intentsity Modulated Total Marrow Irradiation (IM-TMI) In Allogeneic Stem Cell Transplant For High Risk Hematologic Malignancies: A Phase I Study

Phase I-II Trial of Tandem Autologous Transplantation with Melphalan Followed by Total Marrow Irradiation Ablative Therapy in Patients with Responding or Stable Mutiple Myeloma.

Matched Cohort Analysis of Allogeneic Hematopoietic Cell Transplantation (HCT) with Total Marrow Irradiation/Fludarabine/Melphalan (TFM) Versus Fludarabine/Melphalan (FM) Conditioning for Acute Leukemia

Linac Based Total Marrow Irradiation and Myeloablative Chemotherapy In Allogeneic Stem Cell Transplantation for High Risk Patients.

Total Marrow Irradiation (TMI): A New Ablative Regimen as Part of Tandem (T) Autologous Peripheral Blood Progenitor Cell Transplant (AT) for Patients (pts) with Multiple Myeloma (MM).

A Randomized Comparison of Total-Marrow Irradiation, Busulfan and Cyclophosphamide with Tandem High-Dose Melphalan in Patients with Multiple Myeloma.

Total Marrow Irradiation (TMI) with Helical Tomotherapy and PBPC Following High-Dose Melphalan and PBPC as Part of Tandem Therapy for Patients with Multiple Myeloma.

Single High-Dose Chemoradiotherapy Versus Tandem High Dose Melphalan Followed by Auto-SCT for Advanced Multiple Myeloma. Preliminary Analysissis.

Tumor Necrosis Factor-α-Converting Enzyme (ADAM17) Mediates GPIbα Shedding from Platelets In Vitro and In Vivo .

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only